|1.||Liu, Jing: 5 articles (04/2015 - 12/2004)|
|2.||Kornienko, Alexander: 4 articles (02/2014 - 10/2009)|
|3.||Kiss, Robert: 4 articles (02/2014 - 10/2009)|
|4.||Evidente, Antonio: 4 articles (02/2014 - 10/2009)|
|5.||Mathieu, Véronique: 4 articles (02/2014 - 10/2009)|
|6.||Ye, Mao: 3 articles (04/2015 - 12/2004)|
|7.||Andolfi, Anna: 3 articles (12/2011 - 10/2009)|
|8.||Lamoral-Theys, Delphine: 3 articles (12/2011 - 10/2009)|
|9.||Hu, Wei-Xin: 3 articles (01/2010 - 12/2004)|
|10.||Pelly, Stephen C: 2 articles (02/2014 - 12/2011)|
04/01/2015 - "Lycorine, a natural alkaloid, has been widely reported to possess potential efficacy against cancer. "
01/01/2012 - "This study was to prepare a mannosylated lycorine lipid nano-emulsion formulation (M-LYC-OA-LNEs) for the aim of achieving tumor targeting delivery of lycorine (LYC) . "
05/01/2007 - "To determine whether lycorine has an anti-tumor effect in vivo, a series of experiments were carried out in this study. "
06/20/2015 - "Importantly, anti-cancer effects of Lycorine were dependent on STAT expression. "
06/20/2015 - "Lycorine, a natural alkaloid extracted from the Amaryllidaceae plant family, has been reported to exhibit a wide range of physiological effects, including the potential effect against cancer. "
|2.||Glioblastoma (Glioblastoma Multiforme)
12/01/2011 - "1,2-Di-O-allyllycorine was identified as a lycorine analogue, which is 100 times more potent against a U373 human glioblastoma model than the parent natural product. "
10/22/2009 - "Thus, the results of the current study make lycorine an excellent lead for the generation of compounds able to combat cancers, which are naturally resistant to proapoptotic stimuli, such as glioblastoma, melanoma, non-small-cell-lung cancers, and metastatic cancers, among others."
07/23/2010 - "Altogether, the data from the present study revealed that lycorine (1), amarbellisine (6), haemanthamine (14), and haemanthidine (15) are potentially useful chemical scaffolds to generate further compounds to combat cancers associated with poor prognoses, especially those naturally resistant to apoptosis, such as glioblastoma, melanoma, non-small-cell lung, and metastatic cancers."
04/01/2015 - "Our results elucidate the new mechanism of lycorine against multiple myeloma. "
04/01/2015 - "However, the anti-multiple myeloma mechanism of lycorine is not fully understood. "
04/01/2015 - "In this study, the results demonstrated that lycorine is effective against multiple myeloma cell line ARH-77 via inducing programmed necrosis. "
01/01/2012 - "In our previous study, we found that lycorine decrease the cell viability of leukemia HL-60 cells and multiple myeloma KM3 cells and induces cell apoptosis. "
04/01/2015 - "Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77."
|5.||Prostatic Neoplasms (Prostate Cancer)
06/20/2015 - "However, the anti-prostate cancer (PCa) efficacy of Lycorine remains unrevealed. "
06/20/2015 - "We suggest that Lycorine is a potential therapeutic in prostate cancer. "
06/20/2015 - "Here we showed that Lycorine decreased proliferation, migration, invasion, survival and EMT of prostate cancer cell lines. "
06/20/2015 - "Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer."
|4.||Leukocyte L1 Antigen Complex (Calgranulin)
|7.||CD40 Ligand (CD40L)
|9.||Oleic Acid (Oleate)
|10.||Reactive Oxygen Species (Oxygen Radicals)
|1.||Heterologous Transplantation (Xenotransplantation)